Abstract

Cancer is a group of diseases caused by loss of cell cycle control. Cancer is associated with abnormal, uncontrolled cell growth. Colon cancer is the second most common cancer in females and the third most in males worldwide. The rate of colon cancer was low in India. But at present, it is increasing out 3.5 million cancer cases, 35,000 have colon cancer. Polyps, which are the small growths in the colon, are most often benign, even though some have the potential to become cancerous. For cancer treatment, 5-Fluorouracil (5-Fu) is commonly used as a chemotherapeutic drug. 1,2-Dimethylhydrazine (DMH) is a potent colon carcinogen inducer. These colorectal tumours share many resemblances to human colorectal cancer, including similar responses to promotional and preventive agents. This review article highlights various In vivo studies on colon cancer induced by 1,2-Dimethylhydrazine (DMH) and treated by standard drugs with the help of parameters like Aberrant crypt foci (ACF), Histopathology of the colon, Haematological parameters etc.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.